UnknownPhase 4NCT05525234

A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus

Studying Uremic pruritus

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
RenJi Hospital
Principal Investigator
Renhua Lu, Doctor
Ren Ji Hospital, School of Medicine Shanghai Jiao Tong University
Intervention
Thalidomide(drug)
Enrollment
40 target
Eligibility
18-75 years · All sexes
Timeline
2022 – 2023

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05525234 on ClinicalTrials.gov

Other trials for Uremic pruritus

Additional recruiting or active studies for the same condition.

See all trials for Uremic pruritus →

← Back to all trials